Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1529989rdf:typepubmed:Citationlld:pubmed
pubmed-article:1529989lifeskim:mentionsumls-concept:C0357126lld:lifeskim
pubmed-article:1529989lifeskim:mentionsumls-concept:C0205360lld:lifeskim
pubmed-article:1529989lifeskim:mentionsumls-concept:C0033086lld:lifeskim
pubmed-article:1529989lifeskim:mentionsumls-concept:C1883712lld:lifeskim
pubmed-article:1529989lifeskim:mentionsumls-concept:C1280519lld:lifeskim
pubmed-article:1529989pubmed:issue6lld:pubmed
pubmed-article:1529989pubmed:dateCreated1992-10-19lld:pubmed
pubmed-article:1529989pubmed:abstractTextThe stability, potency, and preservative effectiveness of two dilutions of epoetin alfa containing a bacteriostatic diluent were studied. Epoetin alfa 10,000 units/mL in single-use vials was diluted 1:1 and 1:1.5 with bacteriostatic 0.9% sodium chloride injection. USP tests of preservative effectiveness were performed on samples from two batches each of the 1:1 and the 1:1.5 dilutions. Appearance assessment, Western blot analysis, radioimmunoassay, and bioassay were used to determine the stability or potency of samples from three batches of each dilution that were stored at 5 degrees C or at 30 degrees C for 12 weeks. Both batches of the 1:1.5 dilution (epoetin alfa 4,000 units/mL with 0.54% benzyl alcohol) met the USP criteria for preserved solutions, while one batch of the 1:1 dilution (epoetin alfa 5,000 units/mL with 0.45% benzyl alcohol) did not. Epoetin alfa 10,000 units/mL diluted either 1:1 or 1:1.5 with bacteriostatic 0.9% sodium chloride injection and stored at 5 degrees C or at 30 degrees C remained stable and potent for 12 weeks. The addition of 1.5 mL of bacteriostatic 0.9% sodium chloride injection to a vial containing 1 mL of epoetin alfa 10,000 units/mL makes a solution of epoetin alfa 4,000 units/mL that meets the USP criteria for preservative effectiveness and remains stable and potent for 12 weeks at 5 degrees C.lld:pubmed
pubmed-article:1529989pubmed:languageenglld:pubmed
pubmed-article:1529989pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1529989pubmed:citationSubsetIMlld:pubmed
pubmed-article:1529989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1529989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1529989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1529989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1529989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1529989pubmed:statusMEDLINElld:pubmed
pubmed-article:1529989pubmed:monthJunlld:pubmed
pubmed-article:1529989pubmed:issn0002-9289lld:pubmed
pubmed-article:1529989pubmed:authorpubmed-author:NashR ARAlld:pubmed
pubmed-article:1529989pubmed:authorpubmed-author:SharmaBBlld:pubmed
pubmed-article:1529989pubmed:authorpubmed-author:SuddithR LRLlld:pubmed
pubmed-article:1529989pubmed:authorpubmed-author:CorboD CDClld:pubmed
pubmed-article:1529989pubmed:issnTypePrintlld:pubmed
pubmed-article:1529989pubmed:volume49lld:pubmed
pubmed-article:1529989pubmed:ownerNLMlld:pubmed
pubmed-article:1529989pubmed:authorsCompleteYlld:pubmed
pubmed-article:1529989pubmed:pagination1455-8lld:pubmed
pubmed-article:1529989pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:meshHeadingpubmed-meshheading:1529989-...lld:pubmed
pubmed-article:1529989pubmed:year1992lld:pubmed
pubmed-article:1529989pubmed:articleTitleStability, potency, and preservative effectiveness of epoetin alfa after addition of a bacteriostatic diluent.lld:pubmed
pubmed-article:1529989pubmed:affiliationR. W. Johnson Pharmaceutical Research Institute, Raritan, NJ 08869.lld:pubmed
pubmed-article:1529989pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1529989lld:pubmed